| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0018 | 1 |